Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study

Authors Information
Article Notes and Dates
To Cite : Rezaee R, Aghcheli B, Poortahmasebi V, Qorbani M, Alavian S M, et al. Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study, Hepat Mon. 2015 ;15(5):e23618. doi: 10.5812/hepatmon.15(4)2015.23618.
Copyright: Copyright © 2015, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Context
2. Evidence Acquisition
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Ding X, Yang Y, Han B, Du C, Xu N, Huang H, et al. Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation. PLoS One. 2014; 9(5)[DOI][PubMed]
  • 2. WHO . Expanded programme on immunisation Report of 14th Global Advisory Group. 1991;
  • 3. Thomas HC., Lok A., Locarnini E., Zuckerman A.. Variants of Hepatitis B Surface Antigen (HBsAg) 2014; : 107-26
  • 4. Zuckerman JN. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production. J Med Virol. 1996; 50(4): 283-8[DOI][PubMed]
  • 5. Milich DR, Leroux-Roels GG. Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev. 2003; 2(5): 248-57[PubMed]
  • 6. Jilg W, Schmidt M, Deinhardt F. Four-year experience with a recombinant hepatitis B vaccine. Infection. 1989; 17(2): 70-6[PubMed]
  • 7. Chiara F, Bartolucci GB, Cattai M, Piazza A, Nicolli A, Buja A, et al. Hepatitis B vaccination of adolescents: significance of non-protective antibodies. Vaccine. 2013; 32(1): 62-8[DOI][PubMed]
  • 8. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet. 2000; 355(9203): 561-5[PubMed]
  • 9. Saffar MJ, Rezai MS. Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth. Indian Pediatr. 2004; 41(12): 1232-7[PubMed]
  • 10. Behjati Ardakani M,, Mir Hosseini NA,, Ayatollahi J. [Survey of hepatitis B surface antigen titers in vaccinated 8 years old school children of Yazd] Shahid Sadoughi Uni Med Sci And Health svc J 2002; 10(3): 3-7
  • 11. Taghavi Ardakani A, Soltani B, Sharif MR, Moosavi GA, Khademian M. [Evaluation of serum hepatitis B antibody level in vaccinated children after 14 years in Kashan, Iran.] J Gorgan Univ Med Sci. 2012; 14(3): 104-8
  • 12. Hadi N, Hadi N. Assessment of anti-HBs antigen in 6- to 9-year-old children routinely vaccinated via vaccination program in Iran. Med Princ Pract. 2007; 16(4): 306-9[DOI][PubMed]
  • 13. Jafarzadeh A, Montazerifar SJ. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. J Ayub Med Coll Abbottabad. 2006; 18(4): 4-9[PubMed]
  • 14. Afsharian M, Ghaderi M, Vaziri S, Leghaei Z, Ghadiri K, Janbaksh A, et al. [Seroconversion rates after hepatitis-B vaccination in children.] J Kermanshah Univ Med Sci. 2012; 15(6): 481-4
  • 15. Yazdanpanah B, Safari M, Yazdanpanah S. Persistence of HBV Vaccine's Protection and Response to Hepatitis B Booster Immunization in 5- to 7-Year-Old Children in the Kohgiloyeh and Boyerahmad Province, Iran. Hepat Mon. 2010; 10(1): 17-21[PubMed]
  • 16. Mahyar A.. [Survey of Antibody Titers against Recombinant Hepatitis B Vaccination in 6 Years old Children]. 3. 2007; 16(61): 39-43
  • 17. Rafizade B, Kazemi AN, Amir Moghadami HR, Moosavi Nasab N. [Survey of Anti-HBs Serum Level in Vaccinated 7-9 Year-old Children in Zanjan City 2004]. ZUMS J. 2004; 12(47): 49-55
  • 18. Mostafavi Zadeh K, Salehi H, Imani R, Haghayegh MR. Antibody level against of hepatitis B surface antigen after vaccination in children aged 5 to 6 years old after the newly school in the city shahrekord. Res Med Sci. 2001; 6(3): 194-194
  • 19. Esmaili M, Seyedkolal F. [Evaluation of anti HBS levels in vaccinated children against Hepatitis B, Amirkola Hospital, Babol] KAUMS J ( FEYZ ) 2003; 6(4): 45-49
  • 20. Shamsizadeh A, Makvandi M, Shoshtari G. Prevalence of anti hepatitis B surface antibody among children in Ahvaz, Iran, five years after vaccination. Jundishapur J Microbiol. 2011; 4(1)
  • 21. Hosseini SM, Ranjbar R, Abolghasemi H, Turkaman M. Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran. Hepat Mon. 2009; 9(2): 150-3
  • 22. Salehi H, Farajzadegan Z. Antibody titer in Iranian children 6 years after hepatitis B vaccine administration. Vaccine. 2007; 25(17): 3511-4[DOI][PubMed]
  • 23. Ahmadi M, Moosavi SM, Jahanfar F. [Comparison of antibody level in post hepatitis B vaccination in children with 12-15 and 21-24 months age]. J Gorgan Univ Med Sci. 2012; 14(2): 59-65
  • 24. Kazemi A, Koosha A, Rafizadeh B, Mousavinasab N, Mahram M. Serum level of anti-hepatitis B surface antigen 6-8 years after hepatitis B vaccination at birth. East Mediterr Health J. 2008; 14(4): 960-5[PubMed]
  • 25. Azarkar Z. [Efficacy of hepatitis B vaccine in children from 12 to 16 months in Mashad health centers]. J Qazvin Univ of Med Sci. 2004; 7(5): 38-41
  • 26. Dahifar H. Immunogenicity of Cuban hepatitis B vaccine in Iranian children. Arch Iranian Med. 2004; 7(2): 89-92
  • 27. Jafarzadeh A, Khoshnoodi J, Ghorbani S, Hazrati SM, Mazaheri BF, Shokri F. Differential Immunogenicity of A Recombinant Hepatitis B Vaccine in Iranian Neonates: Influence of Ethnicity and Environmental Factors. Int J Infect. 2004; 1(2): 98
  • 28. Fatolah Poor A, Hematpoor S, Ghaderi E. Effect of hepatitis B vaccination in children vaccinated between 12 and 24 months old city of Sanandaj. Journal of Infectious Diseases. 2008; 41(1): 65-70
  • 29. Salehi M, Sanei Moghadam E, Khosravi S. [Evaluation of immune response of Hepatitis B vaccination in Zahedan infants.] Zahedan J Res Med Sci. 2002; 4(3): 155-8
  • 30. Moradi A. [The response rate to hepatitis B vaccination in children younger than one year of Gorgan.] J Gorgan Univ Med Sci. 2008; 10(2): 50-5
  • 31. Zamani A, Shajari H, Sedighy I. Study On The Ef Ficacy Of Recombinant Hepatitis B Vaccine In Iranian Infants. Med J Islamic Repub Iran. 2001; 14(4): 347-9
  • 32. Shokri F, Jafarzadeh A. High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates. Vaccine. 2001; 19(31): 4544-8[PubMed]
  • 33. Rostami N, Ghaffari V, Samaie H. Comparison of Immune Response to Hepatitis B Vaccine Between Term and Preterm Infants at Birth. Arch Clin Infect Dis. 2006; 7(1): 11-4
  • 34. Rezaei M, Nooripoor S, Ghorbani R, Ramezan Shams F, Mamishi S, Mahmoudi S. Seroprotection after hepatitis B vaccination in children aged 1 to 15 years in central province of Iran, Semnan. J prev med hyg. 2014; 55(1): 1-3
  • 35. Elian F, Shubair M. Evaluation of the efficacy of Hepatitis B vaccine in different age groups of immunized children in Gaza strip. Islamic Univ J. 2006; 14(1): 91-103
  • 36. Livramento A, Cordova CM, Scaraveli NG, Tonial GC, Spada C, Treitinger A. Anti-HBs levels among children and adolescents with complete immunization schedule against hepatitis B virus. A cross-sectional study in Blumenau, State of Santa Catarina, Brazil, 2007-2008. Rev Soc Bras Med Trop. 2011; 44(4): 412-5[PubMed]
  • 37. Madour A, Alkout A, Vanin S. First evaluation of the serum level of anti-hepatitis B surface antigen after vaccination in Libya. East Mediterr Health J. 2013; 19(12): 990-4[PubMed]
  • 38. Zanetti AR, Mariano A, Romano L, D'Amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005; 366(9494): 1379-84[DOI][PubMed]
  • 39. Dong Y, Liu SL, Zhai XJ, Zhu FC, Pan H, Yu JX, et al. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China. J Med Virol. 2009; 81(9): 1517-24[DOI][PubMed]
  • 40. Sallam TA, Alghshm HM, Ablohom AA, Alarosi MS, Almotawakel RE, Farea NH, et al. Immune response to Hepatitis B vaccine among children in Yemen. Saudi Med J. 2005; 26(2): 281-4[PubMed]
  • 41. Belloni C, Chirico G, Pistorio A, Orsolini P, Tinelli C, Rondini G. Immunogenicity of hepatitis B vaccine in term and preterm infants. Acta Paediatr. 1998; 87(3): 336-8[PubMed]
  • 42. Hwang LY, Beasley RP, Stevens CE, Szmuness W. Immunogenicity of HBV vaccine in healthy Chinese children. Vaccine. 1983; 1(1): 10-2[PubMed]
  • 43. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health. 2006; 11(10): 1496-502[DOI][PubMed]
  • 44. Sadeck LS, Ramos JL. [Immune response of preterm infants to hepatitis B vaccine administered within 24 hours after birth]. J Pediatr (Rio J). 2004; 80(2): 113-8[PubMed]
  • 45. Aypak C, Yuce A, Yikilkan H, Gorpelioglu S. Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children. Eur J Pediatr. 2012; 171(12): 1761-6[DOI][PubMed]
  • 46. Liao SS, Li RC, Li H, Yang JY, Zeng XJ, Gong J, et al. Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine. 1999; 17(20-21): 2661-6[PubMed]
  • 47. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med. 2005; 142(5): 333-41[PubMed]
  • 48. Hofmann F, Kralj N. Criteria for successful hepatitis B vaccination in adults: results of a case study. Infection. 2009; 37(3): 266-9[DOI][PubMed]
  • 49. Boot HJ, van der Waaij LA, Schirm J, Kallenberg CG, van Steenbergen J, Wolters B. Acute hepatitis B in a healthcare worker: a case report of genuine vaccination failure. J Hepatol. 2009; 50(2): 426-31[DOI][PubMed]
  • 50. Rosenberg C, Bovin NV, Bram LV, Flyvbjerg E, Erlandsen M, Vorup-Jensen T, et al. Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen. Hum Vaccin Immunother. 2013; 9(7): 1466-76[DOI][PubMed]
  • 51. do Livramento A, Schultz J, Batista KZ, Treitinger A, de Cordova CM, Spada C. Immune memory response induced in vitro by recombinant hepatitis B surface antigen challenge 13-18 years after primary vaccination. J Med Virol. 2014; 86(10): 1700-4[DOI][PubMed]
  • 52. Karimzadeh H, Pakzad SR, Mahmoudi M, Ajdary S, Norouzi M, Akbari M. [Set up of analytical methods for evaluation of specifications of recombinant Hepatitis-B vaccine]. Tehran Unive Med Sci. 2009; 67(3)
  • 53. Karimzadeh H, Ajdary S, Jazayeri SM, Pakzad SR. Validation of an in-vitro method for Hepatitis B vaccine potency assay: specification setting. Panminerva Med. 2010; 52(3): 177-82[PubMed]
  • 54. Davaalkham D, Ojima T, Wiersma S, Lkhagvasuren T, Nymadawa P, Uehara R, et al. Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nationwide survey. J Epidemiol Community Health. 2007; 61(7): 578-84[DOI][PubMed]
  • 55. de la Hoz F, Perez L, de Neira M, Hall AJ. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. Int J Infect Dis. 2008; 12(2): 183-9[DOI][PubMed]
  • 56. De La Hoz F, Hall AJ. Hepatitis B Vaccination In The Colombian Amazon Effectiveness And Factors Influencing Vaccination Coverage. 2002;
  • 57. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis. 2009; 200(1): 39-47[DOI][PubMed]
  • 58. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 59. Alavian SM, Hajarizadeh B, -Asl MA, Kabir A, Lankarani KB. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008; 8(4): 281-94
  • 60. Delavari M, Shahabinejhad N, Renzaho A, Zahedi M, Owhadi AR. Frequency of Anti-HBc & HBV DNA detection in blood donors of Kerman province, Iran. J Blood Disord Transfus. 2011; 2(1): 1-4
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check